GWAS identified MSX2, IFLTD1, and PTPRD as replicated loci for resistant HTN, supporting a genetic basis for drug-resistant BP via vascular remodeling and signal transduction pathways. This evidence concerns the gene MSX2 and hypertensive disorder.